ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CIZ Cizzle Biotechnology Holdings Plc

1.70
0.05 (3.03%)
Last Updated: 09:00:04
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cizzle Biotechnology Holdings Plc LSE:CIZ London Ordinary Share GB00BNG2VN02 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 3.03% 1.70 1.60 1.80 1.70 1.65 1.65 898,943 09:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -912k -0.0025 -6.60 6M
Cizzle Biotechnology Holdings Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker CIZ. The last closing price for Cizzle Biotechnology was 1.65p. Over the last year, Cizzle Biotechnology shares have traded in a share price range of 1.65p to 3.60p.

Cizzle Biotechnology currently has 363,841,773 shares in issue. The market capitalisation of Cizzle Biotechnology is £6 million. Cizzle Biotechnology has a price to earnings ratio (PE ratio) of -6.60.

Cizzle Biotechnology Share Discussion Threads

Showing 2926 to 2949 of 3000 messages
Chat Pages: 120  119  118  117  116  115  114  113  112  111  110  109  Older
DateSubjectAuthorDiscuss
21/3/2024
21:38
Which market rules do you think have been breached ?
oapknob1
21/3/2024
21:13
Thanks for the copy & paste. What is your opinion?
geoff98
21/3/2024
20:14
The Texas Business Organizations Code ("BOC") requires every domestic or foreign filing entity to maintain a registered agent and office in Texas. The BOC also permits the filing of an appointment of agent for service of process by an unincorporated nonprofit association. Additionally, the Texas Finance Code permits a Texas financial institution to appoint an agent for service of process.An entity's registered agent is an agent of the entity on whom may be served any process, notice, or demand required or permitted by law to be served on the entity. Section 5.201(b) of the BOC requires that registered agents designated on or after January 1, 2010 must have consented to serve in that capacity in a written or electronic form developed by the Office of the Secretary of State. See Form 401-A (Word, PDF) and 1 Tex. Admin. Code § 79.29.What is a registered office?An entity's registered office must be a physical address in Texas where the registered agent can be served with process during business hours. The registered office is also where the Office of the Secretary of State will mail correspondence. A registered office is the business office address of the registered agent and may be the same as the entity's place of business. It cannot, however, be a post office box that is part of a commercial mail or message service unless that commercial enterprise is the registered agent.
oapknob1
21/3/2024
18:11
Here was me thinking this was a discussion board. Didn't think I'd be subject to an interrogation lol.

Some of those who are invested might be interested to know why someone related to the company by virtue of a 'partnership' (detail largely unknown) has set up a company in the US & called it Cizzle Biotech! I would say that would be a reasonable question.

They might also be interested to know why the Cizzle they are invested in has made no announcement to that effect. The fact that the details of the new company have been published is, in effect, an announcement, but not one made to the shareholders.

Will the 'announcement' of the new US company have a material impact on the share price? Almost certainly, yes, in my view. One way or another.

Anyone who wants to pitch in on the discussion of these issues is welcome, but please don't start demanding that I answer your questions or justify my post.

geoff98
21/3/2024
16:49
Which part of the US is Portugal in ?
oapknob1
21/3/2024
16:37
Ciz s located at York university its partners are USA based.
bollockks
21/3/2024
15:21
I didn't say you were wrong.I was asking what rules you think they may have breached.
secretsqu
21/3/2024
15:17
It's a question.
Significant news, material impact on share price, no RNS?
If I'm wrong, just say so.
Seems close to the line to me.

geoff98
21/3/2024
15:15
If you're referring to Cizzle inc in Texas, what particular rules have been broken?
secretsqu
21/3/2024
15:12
search: cizzle
geoff98
21/3/2024
14:41
It's a British Company.
secretsqu
21/3/2024
10:51
With this company set up in US, looks to me like they are in breach of market rules, or very close to it. No?
geoff98
21/3/2024
08:41
I reckon 52 weeks high in coming days!
daar
20/3/2024
15:33
rising, but no news, not a hint for 6 months! i hope it keeps perking up and then i can get out!
abbynat
20/3/2024
14:50
Money moving to APH , excellent profitable healthcare company
blackhorse23
20/3/2024
13:42
Great shout
dplewis1
20/3/2024
11:11
4p incoming - mark my words
supercity
18/3/2024
11:23
Just added
maverickps123
14/3/2024
22:38
Eyes on Texas trade deal.Bill been busy there.Certificate of FormationCompanyCizzle Bio Inc. Filing Date 2024-02-23Filing Number 01335796590004Filing Type Certificate of FormationFiling Code 000000010101Company Number0805434362Agent NameWilliam BehnkeAgent Address1 Charterwood, San Antonio, TX, 78248, USA
oapknob1
11/3/2024
15:37
I agree with your comments, they should provide an update on regular basis.
highrisk1
11/3/2024
15:10
We are delighted to congratulate Bill Behnke on his appointment to the Conquer Cancer Board of Directors. Bill leads Cizzle Biotechnology's business development in the USA and was responsible for identifying and facilitating the Company's deal with CorePath Laboratories, a full-service cancer reference laboratory, to develop and offer Cizzle Biotechnology plc's proprietary early-stage lung cancer test in the USA. Conquer Cancer, the ASCO Foundation, funds research for every cancer, to help every patient, everywhere. Since 1984, its Grants & Awards program has awarded more than $182 million in funding through over 8,700 grants and awards to medical students, residents, fellows, scientists, and oncologists in 88 countries. Bill has decades of success in delivering major revenues and raising capital from VC, PE and private investors. He continues to promote support for major cancer charities and advocacy groups such as the Leukemia and Lymphoma Society, Conquer Cancer, the ASCO Foundation, the AYA Cancer Foundation and the South Texas Blood and Tissue Center.His appointment to the Conquer Cancer Board will enable Bill to further expand his current programme with Cizzle Biotechnology plc, providing access to healthcare corporations, hospitals, clinicians and key opinion leaders involved in driving early-stage cancer detection. Learn more about this great organisation at: www.conquer.org https://brnw.ch/21wHIdG
oapknob1
11/3/2024
14:46
I got a response from IFC Asvisory. I'm not expecting them to make stuff up, but a 6 month gap between any noteworthy news isn't ideal
dplewis1
11/3/2024
14:42
I would be very surprised if anyone answers the phone. Do they even have an office?.
highrisk1
11/3/2024
14:39
Nothing as usual.What do you expect them to do?.
highrisk1
Chat Pages: 120  119  118  117  116  115  114  113  112  111  110  109  Older

Your Recent History

Delayed Upgrade Clock